Cargando…
Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey
PURPOSE: To evaluate palliative care for patients with gynecologic cancer in Japan. MATERIALS AND METHOD: A questionnaire asking facility characteristics, systems to coordinate palliative care, current status of end-of-life care, provision of symptom relief, palliative radiation therapy and chemothe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454609/ https://www.ncbi.nlm.nih.gov/pubmed/27892676 http://dx.doi.org/10.22034/APJCP.2016.17.10.4637 |
_version_ | 1783240858790789120 |
---|---|
author | Futagami, Masayuki Yokoyama, Yoshihito Sato, Tetsumi Hirota, Kazuyoshi Shimada, Muneaki Miyagi, Etsuko Suzuki, Nao Fujimura, Masaki |
author_facet | Futagami, Masayuki Yokoyama, Yoshihito Sato, Tetsumi Hirota, Kazuyoshi Shimada, Muneaki Miyagi, Etsuko Suzuki, Nao Fujimura, Masaki |
author_sort | Futagami, Masayuki |
collection | PubMed |
description | PURPOSE: To evaluate palliative care for patients with gynecologic cancer in Japan. MATERIALS AND METHOD: A questionnaire asking facility characteristics, systems to coordinate palliative care, current status of end-of-life care, provision of symptom relief, palliative radiation therapy and chemotherapy, and cases of death from gynecological cancer, was mailed to facilities treating gynecologic cancer. RESULTS: A total of 115 facilities (29.3% of the total) responded to the questionnaire. Of these, 33.0 (29.0%) had a palliative care ward. End-of-life care was managed by obstetricians and gynecologists in 72.0% of the facilities. The site where end-of-life care was provided was most often a ward in the department where the respondent worked. The waiting period for transfer to a hospice was 2 weeks or more in 52% of facilities. Before the start of primary treatment, pain control was managed by obstetrians and gynecologists in 98.0% of facilities. Palliative radiation therapy or chemotherapy was administered at 93.9% and 92.0% of facilities, respectively. Of the 115 facilities, 34.0 (29.6%) reported cases of death from gynecological cancer. There were 1,134 cases of death. The median time between the last cycle of chemotherapy and death was 85 days for all gynecological cancers. The proportion of patients receiving chemotherapy in the last 30 and 14 days of life were 17.4% and 7.1%, respectively. CONCLUSIONS: This large-scale survey showed characteristics of palliative care given to patients with gynecologic cancer in Japan. Assessment of death cases showed that the median time between the last cycle of chemotherapy and death was relatively short. |
format | Online Article Text |
id | pubmed-5454609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-54546092017-08-28 Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey Futagami, Masayuki Yokoyama, Yoshihito Sato, Tetsumi Hirota, Kazuyoshi Shimada, Muneaki Miyagi, Etsuko Suzuki, Nao Fujimura, Masaki Asian Pac J Cancer Prev Research Article PURPOSE: To evaluate palliative care for patients with gynecologic cancer in Japan. MATERIALS AND METHOD: A questionnaire asking facility characteristics, systems to coordinate palliative care, current status of end-of-life care, provision of symptom relief, palliative radiation therapy and chemotherapy, and cases of death from gynecological cancer, was mailed to facilities treating gynecologic cancer. RESULTS: A total of 115 facilities (29.3% of the total) responded to the questionnaire. Of these, 33.0 (29.0%) had a palliative care ward. End-of-life care was managed by obstetricians and gynecologists in 72.0% of the facilities. The site where end-of-life care was provided was most often a ward in the department where the respondent worked. The waiting period for transfer to a hospice was 2 weeks or more in 52% of facilities. Before the start of primary treatment, pain control was managed by obstetrians and gynecologists in 98.0% of facilities. Palliative radiation therapy or chemotherapy was administered at 93.9% and 92.0% of facilities, respectively. Of the 115 facilities, 34.0 (29.6%) reported cases of death from gynecological cancer. There were 1,134 cases of death. The median time between the last cycle of chemotherapy and death was 85 days for all gynecological cancers. The proportion of patients receiving chemotherapy in the last 30 and 14 days of life were 17.4% and 7.1%, respectively. CONCLUSIONS: This large-scale survey showed characteristics of palliative care given to patients with gynecologic cancer in Japan. Assessment of death cases showed that the median time between the last cycle of chemotherapy and death was relatively short. West Asia Organization for Cancer Prevention 2016 /pmc/articles/PMC5454609/ /pubmed/27892676 http://dx.doi.org/10.22034/APJCP.2016.17.10.4637 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Research Article Futagami, Masayuki Yokoyama, Yoshihito Sato, Tetsumi Hirota, Kazuyoshi Shimada, Muneaki Miyagi, Etsuko Suzuki, Nao Fujimura, Masaki Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey |
title | Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey |
title_full | Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey |
title_fullStr | Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey |
title_full_unstemmed | Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey |
title_short | Palliative Care for Patients with Gynecologic Cancer in Japan: A Japan Society of Gynecologic Palliative Medicine (JSGPM) Survey |
title_sort | palliative care for patients with gynecologic cancer in japan: a japan society of gynecologic palliative medicine (jsgpm) survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454609/ https://www.ncbi.nlm.nih.gov/pubmed/27892676 http://dx.doi.org/10.22034/APJCP.2016.17.10.4637 |
work_keys_str_mv | AT futagamimasayuki palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey AT yokoyamayoshihito palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey AT satotetsumi palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey AT hirotakazuyoshi palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey AT shimadamuneaki palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey AT miyagietsuko palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey AT suzukinao palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey AT fujimuramasaki palliativecareforpatientswithgynecologiccancerinjapanajapansocietyofgynecologicpalliativemedicinejsgpmsurvey |